myocardial reinfarction - case report
Keywords:
acute myocardial infarction, reinfarct, prehospital treatment
Abstract
Introduction: According to the Fourth Universal Definition of Myocardial Infarction (MI), the term ″reinfarction″ is clinically used for MI occurring within 28 days of an incident or recurrent MI. It is characterized by the recurrence of anginal pain, an increase in cardiospecific enzymes and changes in the electrocardiogram.
Aim: To point out the importance of early recognition and prehospital diagnosis of myocardial reinfarction that occurred shortly after the first MI, with implications for a positive patient outcome.
Case report: A 64-year-old female called 194 because of chest pain accompanied by vomiting. Discharged two days earlier after hospitalization for anterior wall MI. Changes in the ST segment are observed on the ECG recording, which indicate an MI anterolateral localization. Appropriate therapy, he was transported to the angio room for further diagnosis and treatment.
Conclusion: Fast and timely diagnosis of reinfarction plays a key role in the further treatment of the patient.
References
1. Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022;399(10332):1347-58. doi:10.1016/S0140-6736(21)02391-6
2. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes [published correction appears in Eur Heart J. 2024;45(13):1145. doi: 10.1093/eurheartj/ehad870.]. Eur Heart J. 2023;44(38):3720-3826. doi:10.1093/eurheartj/ehad191
3. Radovanović N, Radosavljević-Radovanović M, Dobrić M, Antonijević N, Mitrović P. Akutni infarkt miokarda – pravovremenost i povezanost u zbrinjavanju bolesnika. Acta chirurgica Jugoslavica. 2016; 63(2): 9-13. doi:10.2298/ACI1602009R.
4. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards) Cannon CP, Brindis RG, Chaitman BR, et al. J Am Coll Cardiol. 2013;61:992–1025. doi: 10.1016/j.jacc.2012.10.005.
5. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618-e651. doi: 10.1161/CIR.0000000000000617. PMID: 30580786.
6. De Luca L, Paolucci L, Nusca A, Putini RL, Mangiacapra F, Natale E, et al. Current management and prognosis of patients with recurrent myocardial infarction. Rev Cardiovasc Med. 2021;22(3):731-740. doi: 10.31083/j.rcm2203080. PMID: 34565072.
7. Schmitz T, Harmel E, Heier M, Peters A, Linseisen J, Meisinger C. Long-Term Predictors of Hospitalized Reinfarction after an Incident Acute Myocardial Infarction. Life (Basel). 2022;12(12):2090. doi: 10.3390/life12122090. PMID: 36556454; PMCID: PMC9784794.
8. Abreu LM. Time is Muscle. Arq Bras Cardiol. 2019;112(4):408-9. doi: 10.5935/abc.20190059. PMID: 30994719; PMCID: PMC6459437.
9. Nair R, Johnson M, Kravitz K, Huded C, Rajeswaran J, Anabila M, et al. Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction. J Am Heart Assoc. 2021;10(16):e019270. doi: 10.1161/JAHA.120.019270. PMID: 34333986.
10. Butler J, Hammonds K, Talha KM, Alhamdow A, Bennett MM, Bomar JVA, et al. Incident heart failure and recurrent coronary events following acute myocardial infarction. Eur Heart J. 2025:ehae885. doi: 10.1093/eurheartj/ehae885. PMID: 39874177.
11. Agencija za lekove i medicinska sredstva Srbije. Uputstvo za lek: Furosemid Sopharma 10 mg/ml. Dostupno na: https://www.alims.gov.rs/doc_file/lekovi/pil/515-01-00728-20-001.pdf. Pristupljeno: 16.03.2024.
2. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes [published correction appears in Eur Heart J. 2024;45(13):1145. doi: 10.1093/eurheartj/ehad870.]. Eur Heart J. 2023;44(38):3720-3826. doi:10.1093/eurheartj/ehad191
3. Radovanović N, Radosavljević-Radovanović M, Dobrić M, Antonijević N, Mitrović P. Akutni infarkt miokarda – pravovremenost i povezanost u zbrinjavanju bolesnika. Acta chirurgica Jugoslavica. 2016; 63(2): 9-13. doi:10.2298/ACI1602009R.
4. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards) Cannon CP, Brindis RG, Chaitman BR, et al. J Am Coll Cardiol. 2013;61:992–1025. doi: 10.1016/j.jacc.2012.10.005.
5. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618-e651. doi: 10.1161/CIR.0000000000000617. PMID: 30580786.
6. De Luca L, Paolucci L, Nusca A, Putini RL, Mangiacapra F, Natale E, et al. Current management and prognosis of patients with recurrent myocardial infarction. Rev Cardiovasc Med. 2021;22(3):731-740. doi: 10.31083/j.rcm2203080. PMID: 34565072.
7. Schmitz T, Harmel E, Heier M, Peters A, Linseisen J, Meisinger C. Long-Term Predictors of Hospitalized Reinfarction after an Incident Acute Myocardial Infarction. Life (Basel). 2022;12(12):2090. doi: 10.3390/life12122090. PMID: 36556454; PMCID: PMC9784794.
8. Abreu LM. Time is Muscle. Arq Bras Cardiol. 2019;112(4):408-9. doi: 10.5935/abc.20190059. PMID: 30994719; PMCID: PMC6459437.
9. Nair R, Johnson M, Kravitz K, Huded C, Rajeswaran J, Anabila M, et al. Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction. J Am Heart Assoc. 2021;10(16):e019270. doi: 10.1161/JAHA.120.019270. PMID: 34333986.
10. Butler J, Hammonds K, Talha KM, Alhamdow A, Bennett MM, Bomar JVA, et al. Incident heart failure and recurrent coronary events following acute myocardial infarction. Eur Heart J. 2025:ehae885. doi: 10.1093/eurheartj/ehae885. PMID: 39874177.
11. Agencija za lekove i medicinska sredstva Srbije. Uputstvo za lek: Furosemid Sopharma 10 mg/ml. Dostupno na: https://www.alims.gov.rs/doc_file/lekovi/pil/515-01-00728-20-001.pdf. Pristupljeno: 16.03.2024.
Published
2025/04/28
Section
Case report
Autori koji objavljuju u ovom časopisu pristaju na sledeće uslove:
- Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.
- Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.
- Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).